2,6-Xylidine - re-evaluation of the carcinogenicity and genotoxicity
Health Council of the Netherlands
            Record ID 32016000064
            English
                                                            
                Authors' recommendations:
                The committee concludes that 2,6-xylidine is suspected to be carcinogenic to man, and recommends classifying the compound in category 2. Based on the available data, the committee furthermore recommends classifying the substance as a germ cell mutagen in category 2 (Substances which cause concern for humans owing to the possibility that they may induce heritable mutations in the germ cells of humans). The substance acts by a stochastic genotoxic mechanism.
            
                                    
            Details
                        
                Project Status:
                Completed
            
                                                            
                Year Published:
                2015
            
                                    
                URL for published report:
                http://www.gezondheidsraad.nl/sites/default/files/201527_26-xylidine.pdf
            
                                                            
                English language abstract:
                An English language summary is available
            
                                    
                Publication Type:
                Not Assigned
            
                                    
                Country:
                Netherlands
            
                                                
                        MeSH Terms
            - Humans
- Aniline Compounds
- Carcinogenicity Tests
- DNA Damage
Contact
                        
                Organisation Name:
                Health Council of the Netherlands Gezondheidsraad
            
            
                        
                Contact Address:
                Postbus 16052, 2500 BB Den Haag, The Netherlands. Tel: +31 70 340 7520;Fax: +31 70 340 7523
            
                                    
                Contact Name:
                info@gr.nl
            
                                    
                Contact Email:
                info@gr.nl
            
                                    
                Copyright:
                Health Council of the Netherlands
            
                    
                This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.